Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Thiophosgene | HCID 10040 | — |
| Reactant | 2-Aminoquinoline | HCID 11379 | — |
| Reactant | 1-Ethyl-3-(3'-dimethylaminopropyl)carbodiimide | HCID 15908 | — |
| Reactant | 2-(2,6-Dichloro-phenyl)-3H-benzoimidazole-5-carboxylic acid hydrazide | HCID 57786585 | — |
| Solvent | Chloroform | HCID 6212 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Solvent | Ethyl Acetate | HCID 8857 | — |
| Solvent | Sodium Bicarbonate | HCID 516892 | — |
| Product | HCID 25235359 | HCID 25235359 | — |
Reaction Steps
Dissolve 2-amino-quinoline (88 mg, 0.607 mmol) in a biphasic solution of CHCl3 (15 mL) and saturated NaHCO3 (15 mL). Add thiophosgene (47 uL, 0.607 mmol) to the organic phase and stir the reaction vigorously for 3 hr. Add 2-(2,6-dichloro-phenyl)-3H-benzoimidazole-5-carboxylic acid hydrazide (150 mg, 0.467 mmol) and stir overnight. Filter the reaction. Extract the aqueous phase with CHCl3 (20 mL). Concentrate the combined organics and combine with the solid. Evaporate the solvent. Add EDCI (96 mg, 0.500 mmol) and DMF (3 mL). Heat to 80° C. for 1 hr. Upon cooling to room temp dilute the reaction with EtOAc (75 mL) and extract with water (15 mL). Dry the organic phase over Na2SO4 and concentrate. Purify the concentrate by reverse phase HPLC (35-65% ACN/H2O+5 mM NH4OH) to afford the title compound as a yellow solid: 1H NMR (400 MHz, MeOD) δ ppm 7.19 (br. s., 1H) 7.45 (m, 1H) 7.55-7.64 (m, 3H) 7.69-7.75 (m, 2H) 7.82 (d, J=7.83 Hz, 2H) 8.05 (dd, J=8.46, 1.52 Hz, 1H) 8.16 (d, J=9.35 Hz, 1H) 8.32 (br. s., 1H); MS m/z=473.0 (M+1).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07879850B2 |
|---|
| Source dataset | uspto-grants-2011_02 |
|---|
| ORD ID | ord-9b4eb789e3954e80af3451f0dec89a6d |
|---|
| Source note | uspto-grants-2011_02 |
|---|